Skip to main content
MIRM logo
MIRM
(NASDAQ)
Mirum Pharmaceuticals, Inc.
$92.49-- (--)
Loading... - Market loading

Mirum Pharmaceuticals (MIRM) Stock Price & Financial Analysis

Mirum Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$91.92 - $95.25
52-Week High$114.99
52-Week Low$43.50
Open$92.10
Volume690.58K
Average Volume (3M)1.09M
Market Cap4.61B
Shares Outstanding50.20M
Price to Sales (P/S)8.88
Price to Book (P/B)14.70
EV/EBITDA333.18
Revenue (TTM)521.31M
Net Income (TTM)-23.36M
Free Cash Flow (TTM)54.87M
EPS (TTM)$-0.45
Profit Margin-4.48%
Operating Margin-4.25%
Return on Equity (ROE)-7.42%
Debt to Equity1.02
50-Day MA$97.32
200-Day MA$84.68
52-Week Change102.77%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Mirum Pharmaceuticals

What is the current stock price for MIRM?

As of the latest trading session, MIRM stock trades at $92.49. The 52-week range is $43.50–$114.99, with a day range of $91.92–$95.25.

What is the P/E ratio for MIRM?

The P/E ratio (Price-to-Earnings) for MIRM is shown in the Key Statistics section. This valuation metric helps compare Mirum Pharmaceuticals, Inc. to industry peers.

Does MIRM pay dividends?

Mirum Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for MIRM?

Based on 5 analysts, the consensus for MIRM is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of MIRM?

Mirum Pharmaceuticals's market capitalization is $4.64B, classifying it as a mid-cap company..